UNSPSC 51282805: Propenidazole

This classification denotes an antiprotozoal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F0O89MB7QE. European Medicines Agency schedules Propenidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10101MIG. Propenidazole generally arises in the molecular formula C11H13N3O5.

UNSPSC 51282805 Propenidazole, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The code's title references a specific pharmaceutical compound, yet the two recent opportunities in the state and local record involve other drugs entirely — doxycycline, ciprofloxacin, and naloxone — rather than propenidazole. State and local agencies do procure pharmaceuticals through piggyback contracts and direct competitive bidding, often bundling multiple drug products in single solicitations for warehouse distribution or community health delivery. When propenidazole does appear in state and local procurement, it enters through cooperative purchasing vehicles such as MMCAP Infuse or through county RFQs and IFBs, typically as part of broader pharmaceutical supply agreements rather than standalone line items.

Recent activity appears concentrated in Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (award completed; not an open solicitation), covering doxycycline and ciprofloxacin with a 12-month initial term and two renewal options. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, with a two-year initial term and one-year renewal option. The code shows no active open solicitations currently available and limited recent evidence of state or local demand specifically for propenidazole; activity appears concentrated among state health departments and county public health authorities when pharmaceutical procurement does occur under this classification.